QL |
α-S1-casein |
97–98 |
DPP-IV Inhibitory/anti-diabetic |
Barati et al., 2020
|
EAMPAK |
β-casein |
100–105 |
Antimicrobial |
Sedaghati et al., 2016
|
YY |
α-S1-casein |
165–166 |
ACE-inhibitory |
Fuglsang et al., 2003
|
YLG |
α-S1-casein |
91–93 |
Antioxidant/improves cognitive decline |
del Mar Contreras et al., 2013; Nagai et al., 2019; Amigo et al., 2020
|
EL |
α-S1-casein |
39–40, 141–142, 148–149 |
Antioxidant |
Suetsuna et al., 2000
|
HKEMPFPK |
β-casein |
106–113 |
Antimicrobial |
Sedaghati et al., 2016
|
YL |
α-S1-casein |
91–92, 94–95 |
ACE-inhibitory |
Mullally et al., 1996
|
AVPYPQR |
β-casein |
177–183 |
Antioxidant/Antimicrobial/ACE-inhibitory |
Rival et al., 2001; Tonolo et al., 2020
|
VLPVPQK |
β-casein |
170–176 |
Antioxidant/Antimicrobial/ACE-inhibitory/Wound healing/Osteoanabolic/anti-apoptotic effect |
Shanmugam et al., 2015; Vij et al., 2016; Devi et al., 2020
|
RELEEL |
β-casein |
1–6 |
Antioxidant |
Liu et al., 2020
|
AMKPW |
α-S2-casein |
189–193 |
ACE-inhibitory |
Maeno et al., 1996
|
EMPFPK |
β-casein |
108–113 |
Increase MUC4 expression/Bradykinin-Potentiating/Antimicrobial/ACE-inhibitory |
Pihlanto-Leppälä et al., 1998; Perpetuo et al., 2003; Plaisancié et al., 2015; Sedaghati et al., 2016
|
SDIPNPIGSENSEK |
α-S1-casein |
180–193 |
Antimicrobial |
Hayes et al., 2006
|
VLPVPQ |
β-casein |
170–175 |
Inhibition of cholesterol solubility |
Jiang et al., 2020
|
YPEL |
α-S1-casein |
146–149 |
Antioxidant |
Suetsuna et al., 2000
|
LNVPGEIVE |
β-casein |
6–14 |
ACE-inhibitory |
Gobbetti et al., 2000
|
YPVEPF |
β-casein |
114–119 |
Opioid/Increase MUC4 expression/DPP-IV Inhibitory/Antioxidant/Antimicrobial |
Jinsmaa and Yoshikawa, 1999; Plaisancié et al., 2015; Nongonierma and Fitzgerald, 2016; Nongonierma et al., 2018
|
GPFPI |
β-casein |
203–207 |
Cathepsin B Inhibitory |
Nakagomi et al., 2002
|
VYPFPGPIPN |
β-casein |
59–68 |
Antioxidant |
Eisele et al., 2013
|
VYPFPGPI |
β-casein |
59–66 |
prolyl endopeptidase-inhibitory |
Asano et al., 1992
|
YQEPVLGPVRGPFPIIV |
β-casein |
193–209 |
immunomodulatory, antithrombin, Antimicrobial, ACE-inhibitory, Immunomodulatory |
Yamamoto et al., 1994; Birkemo et al., 2009
|
Gamma-Glu-Tyr |
|
|
DPP-IV Inhibitory, potential functional ingredients in type 2 diabetic diet |
Lu et al., 2021
|
Gamma-Glu-Phe |
|
|
Promotion of cholecystokinin (CCK)/and glucagon-like peptide 1 (GLP-1) secretion |
Lu et al., 2021
|
Gamma-Glu-Leu |
|
|
DPP-IV Inhibitory, potential functional ingredients in type 2 diabetic diet |
Lu et al., 2021
|